Skip to main content
Top
Published in: AIDS Research and Therapy 1/2012

Open Access 01-12-2012 | Research

Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions

Authors: Paulo R Alencastro, Fernando H Wolff, Renato R Oliveira, Maria Letícia R Ikeda, Nêmora T Barcellos, Ajácio B M Brandão, Sandra C Fuchs

Published in: AIDS Research and Therapy | Issue 1/2012

Login to get access

Abstract

Background

Metabolic Syndrome (MetS) is based on the same individual components, but has received several amendments to the original definition. In this study, we verified the prevalence of metabolic syndrome according to different criteria, and the impact of each component on the diagnostic.

Methods

This cross-sectional study enrolled HIV infected patients from a HIV/AIDS reference Center in southern Brazil. Metabolic syndrome was identified according to the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP-ATPIII), the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) criteria, and using a standardized questionnaire and blood testing.

Results

A sample of 1240, out of 1295, HIV-infected patients was enrolled. Males were on average older, more educated, and had shorter time since the HIV diagnosis. The population attributable risk (PAR) for waist circumference explained 80% of the prevalence among men and women (AHA/NHLBI criteria). Triglycerides had the highest impact on prevalence of metabolic syndrome according to all criteria, independently of age, skin color and HAART use, among men.

Conclusions

In this large sample of HIV infected patients, the overall prevalence of metabolic syndrome, under either classification, was noticeable and the AHA/NHLBI definition accounted for the highest prevalence.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337/diacare.28.7.1769CrossRefPubMed Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337/diacare.28.7.1769CrossRefPubMed
2.
go back to reference Lorenzo C, Williams K, Hunt KJ, Haffner SM: The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007, 30: 8-13. 10.2337/dc06-1414CrossRefPubMed Lorenzo C, Williams K, Hunt KJ, Haffner SM: The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007, 30: 8-13. 10.2337/dc06-1414CrossRefPubMed
3.
go back to reference Hall WD, Watkins LO, Wright JT, Wenger NK, Kumanyika SK, Gavin JR, Ferdinand KC, Watson K, Clark LT, Flack JM, Reed JW, Horton EW, Saunders E, African-American Lipid and Cardiovascular Council: The metabolic syndrome: recognition and management. Dis Manag. 2006, 9: 16-33. 10.1089/dis.2006.9.16CrossRefPubMed Hall WD, Watkins LO, Wright JT, Wenger NK, Kumanyika SK, Gavin JR, Ferdinand KC, Watson K, Clark LT, Flack JM, Reed JW, Horton EW, Saunders E, African-American Lipid and Cardiovascular Council: The metabolic syndrome: recognition and management. Dis Manag. 2006, 9: 16-33. 10.1089/dis.2006.9.16CrossRefPubMed
4.
go back to reference Alberti KG, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8CrossRefPubMed Alberti KG, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8CrossRefPubMed
5.
go back to reference Adult Treatment Panel III: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Publication 01-3670. 2002, 1-50. NIH Publication No. 02-5215, National Institutes of Health, Bethesda, MD Adult Treatment Panel III: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Publication 01-3670. 2002, 1-50. NIH Publication No. 02-5215, National Institutes of Health, Bethesda, MD
6.
go back to reference Adult Treatment Panel III : Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421. Adult Treatment Panel III : Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421.
8.
go back to reference Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004, 109: 433-438. 10.1161/01.CIR.0000111245.75752.C6CrossRefPubMed Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004, 109: 433-438. 10.1161/01.CIR.0000111245.75752.C6CrossRefPubMed
9.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404CrossRefPubMed
10.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation TaskForce on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; InternationalAtherosclerosis Society; International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation TaskForce on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; InternationalAtherosclerosis Society; International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644CrossRefPubMed
11.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356CrossRefPubMed
12.
go back to reference Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care. 2004, 27: 2444-2449. 10.2337/diacare.27.10.2444CrossRefPubMed Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care. 2004, 27: 2444-2449. 10.2337/diacare.27.10.2444CrossRefPubMed
13.
go back to reference Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care. 2007, 30: 113-119. 10.2337/dc06-1075CrossRefPubMed Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care. 2007, 30: 113-119. 10.2337/dc06-1075CrossRefPubMed
14.
go back to reference Bonfanti P, Giannattasio C, Ricci E, Facchetti R, Rosella E, Franzetti M, Cordier L, Pusterla L, Bombelli M, Sega R, Quirino T, Mancia G: HIV and metabolic syndrome: a comparison with the general population. J Acquir Immune Defic Syndr. 2007, 45: 426-431. 10.1097/QAI.0b013e318074ef83CrossRefPubMed Bonfanti P, Giannattasio C, Ricci E, Facchetti R, Rosella E, Franzetti M, Cordier L, Pusterla L, Bombelli M, Sega R, Quirino T, Mancia G: HIV and metabolic syndrome: a comparison with the general population. J Acquir Immune Defic Syndr. 2007, 45: 426-431. 10.1097/QAI.0b013e318074ef83CrossRefPubMed
15.
go back to reference Grinspoon SK: Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med. 2005, 118 (Suppl 2): 23S-28S.PubMed Grinspoon SK: Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med. 2005, 118 (Suppl 2): 23S-28S.PubMed
16.
go back to reference Nolan D: Metabolic complications associated with HIV protease inhibitor therapy. Drugs. 2003, 63: 2555-2574. 10.2165/00003495-200363230-00001CrossRefPubMed Nolan D: Metabolic complications associated with HIV protease inhibitor therapy. Drugs. 2003, 63: 2555-2574. 10.2165/00003495-200363230-00001CrossRefPubMed
17.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood PressureEducation Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood PressureEducation Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560CrossRefPubMed
18.
go back to reference SBC : I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol. 2005, 84 (1): S1-S28. 10.1590/S0066-782X2005000100001.CrossRef SBC : I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol. 2005, 84 (1): S1-S28. 10.1590/S0066-782X2005000100001.CrossRef
19.
go back to reference O’Brien E, Mee F, Atkins N, Thomas M: Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit. 1996, 1: 55-61.PubMed O’Brien E, Mee F, Atkins N, Thomas M: Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit. 1996, 1: 55-61.PubMed
20.
go back to reference World Health Organization : Physical status: the use and interpretation of anthropometry. Report of the WHO Expert Committee. World Health Organ Tech Rep Ser. 1995, 854: 1-452. World Health Organization : Physical status: the use and interpretation of anthropometry. Report of the WHO Expert Committee. World Health Organ Tech Rep Ser. 1995, 854: 1-452.
21.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed
22.
go back to reference Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973, 19: 476-482.PubMed Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973, 19: 476-482.PubMed
23.
go back to reference Trinder P: Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969, 22: 158-161. 10.1136/jcp.22.2.158PubMedCentralCrossRefPubMed Trinder P: Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969, 22: 158-161. 10.1136/jcp.22.2.158PubMedCentralCrossRefPubMed
24.
25.
go back to reference Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003, 95: 1404-1413. 10.1093/jnci/djg047CrossRefPubMed Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003, 95: 1404-1413. 10.1093/jnci/djg047CrossRefPubMed
26.
go back to reference Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9CrossRefPubMed Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9CrossRefPubMed
28.
go back to reference Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN: Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med. 1989, 86: 27-31.CrossRefPubMed Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN: Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med. 1989, 86: 27-31.CrossRefPubMed
29.
go back to reference Meenan J, Mooney E, Mosquita N, Johnson AH, Collins P, Feely J, Mulcahy FM: The impact of HIV disease progression on serum lipoproteins. AIDS. 1992, 6: 1551-1552. 10.1097/00002030-199212000-00026CrossRefPubMed Meenan J, Mooney E, Mosquita N, Johnson AH, Collins P, Feely J, Mulcahy FM: The impact of HIV disease progression on serum lipoproteins. AIDS. 1992, 6: 1551-1552. 10.1097/00002030-199212000-00026CrossRefPubMed
30.
go back to reference Jacobson DL, Tang AM, Spiegelman D, Thomas AM, Skinner S, Gorbach SL, Wanke C: Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr. 2006, 43: 458-466. 10.1097/01.qai.0000243093.34652.41CrossRefPubMed Jacobson DL, Tang AM, Spiegelman D, Thomas AM, Skinner S, Gorbach SL, Wanke C: Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr. 2006, 43: 458-466. 10.1097/01.qai.0000243093.34652.41CrossRefPubMed
31.
go back to reference Squillace N, Zona S, Stentarelli C, Orlando G, Beghetto B, Nardini G, Esposito R, Guaraldi G: Detectable HIV Viral Load Is Associated With Metabolic Syndrome. J Acquir Immune Defic Syndr. 2009, 52: 459-464. 10.1097/QAI.0b013e3181b93a23CrossRefPubMed Squillace N, Zona S, Stentarelli C, Orlando G, Beghetto B, Nardini G, Esposito R, Guaraldi G: Detectable HIV Viral Load Is Associated With Metabolic Syndrome. J Acquir Immune Defic Syndr. 2009, 52: 459-464. 10.1097/QAI.0b013e3181b93a23CrossRefPubMed
32.
go back to reference Hansen BR, Petersen J, Haugaard SB, Madsbad S, Obel N, Suzuki Y, Andersen O: The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Med. 2009, 10: 378-387. 10.1111/j.1468-1293.2009.00697.xCrossRefPubMed Hansen BR, Petersen J, Haugaard SB, Madsbad S, Obel N, Suzuki Y, Andersen O: The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Med. 2009, 10: 378-387. 10.1111/j.1468-1293.2009.00697.xCrossRefPubMed
33.
go back to reference Bonfanti P, Ricci E, de Socio G, Zeme D, Carradori S, Penco G, Parruti G, Grosso C, Madeddu G, Vichi F, Bini T, Martinelli C, Melzi S, Quirino T, : Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study. J Acquir Immune Defic Syndr. 2006, 42: 128-131. 10.1097/01.qai.0000219775.20174.2dCrossRefPubMed Bonfanti P, Ricci E, de Socio G, Zeme D, Carradori S, Penco G, Parruti G, Grosso C, Madeddu G, Vichi F, Bini T, Martinelli C, Melzi S, Quirino T, : Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study. J Acquir Immune Defic Syndr. 2006, 42: 128-131. 10.1097/01.qai.0000219775.20174.2dCrossRefPubMed
34.
go back to reference Gus M, Cichelero FT, Moreira CM, Escobar GF, Moreira LB, Wiehe M, Fuchs SC, Fuchs FD: Waist circumference cut-off values to predict the incidence of hypertension: an estimation from a Brazilian population-based cohort. Nutr Metab Cardiovasc Dis. 2009, 19: 15-19. 10.1016/j.numecd.2008.03.007CrossRefPubMed Gus M, Cichelero FT, Moreira CM, Escobar GF, Moreira LB, Wiehe M, Fuchs SC, Fuchs FD: Waist circumference cut-off values to predict the incidence of hypertension: an estimation from a Brazilian population-based cohort. Nutr Metab Cardiovasc Dis. 2009, 19: 15-19. 10.1016/j.numecd.2008.03.007CrossRefPubMed
35.
go back to reference Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM: Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006, 13: 280-285. 10.1097/01.gme.0000177907.32634.aeCrossRefPubMed Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM: Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006, 13: 280-285. 10.1097/01.gme.0000177907.32634.aeCrossRefPubMed
36.
go back to reference Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP: Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin. 2010, 26: 713-719. 10.1185/03007991003590597CrossRefPubMed Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP: Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin. 2010, 26: 713-719. 10.1185/03007991003590597CrossRefPubMed
37.
go back to reference Panagiotakos DB, Pitsavos C, Das UN, Skoumas Y, Stefanadis C: The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis. Diabetes Obes Metab. 2007, 9: 660-668. 10.1111/j.1463-1326.2006.00640.xCrossRefPubMed Panagiotakos DB, Pitsavos C, Das UN, Skoumas Y, Stefanadis C: The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis. Diabetes Obes Metab. 2007, 9: 660-668. 10.1111/j.1463-1326.2006.00640.xCrossRefPubMed
38.
go back to reference Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R: Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003, 14: 101-106. 10.1016/S0953-6205(03)00022-0CrossRefPubMed Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R: Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003, 14: 101-106. 10.1016/S0953-6205(03)00022-0CrossRefPubMed
39.
go back to reference Bernal E, Masia M, Padilla S, Martin-Hidalgo A, Gutierrez F: Prevalence and characteristics of metabolic syndrome among HIV-infected patients from a Mediterranean cohort]. Med Clin (Barc). 2007, 128: 172-175. 10.1157/13098391. quiz 171 p following 200CrossRef Bernal E, Masia M, Padilla S, Martin-Hidalgo A, Gutierrez F: Prevalence and characteristics of metabolic syndrome among HIV-infected patients from a Mediterranean cohort]. Med Clin (Barc). 2007, 128: 172-175. 10.1157/13098391. quiz 171 p following 200CrossRef
40.
go back to reference Jerico C, Knobel H, Montero M, Ordonez-Llanos J, Guelar A, Gimeno JL, Saballs P, López-Colomés JL, Pedro-Botet J: Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care. 2005, 28: 132-137. 10.2337/diacare.28.1.132CrossRefPubMed Jerico C, Knobel H, Montero M, Ordonez-Llanos J, Guelar A, Gimeno JL, Saballs P, López-Colomés JL, Pedro-Botet J: Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care. 2005, 28: 132-137. 10.2337/diacare.28.1.132CrossRefPubMed
Metadata
Title
Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions
Authors
Paulo R Alencastro
Fernando H Wolff
Renato R Oliveira
Maria Letícia R Ikeda
Nêmora T Barcellos
Ajácio B M Brandão
Sandra C Fuchs
Publication date
01-12-2012
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2012
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/1742-6405-9-29

Other articles of this Issue 1/2012

AIDS Research and Therapy 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.